Term
|
Definition
| Non modifiable characteristic (age, gender, race, etc.) |
|
|
Term
|
Definition
explains the relationship between two variables. (In Obesity, we change these through interventions)
e.g. self-efficacy, perceptions, attitudes, and beliefs |
|
|
Term
|
Definition
Where individuals interact.
e.g. work, school, coffee shops, etc. |
|
|
Term
|
Definition
When two or more microsystems interact and influence behavior
Individual must belong to both microsystems |
|
|
Term
|
Definition
| Two or more microsystems interact and influence behavior, however, this influence is on those who don't belong to one of the microsystems. |
|
|
Term
|
Definition
The larger sociocultural context where an individual resides.
Includes social class structure, cultural values, community.
Think of these as subconscious influences.
Macrosystem encompasses micro, meso, and exosystems |
|
|
Term
| Prevalence of the obesity epidemic is calculated from _________________. |
|
Definition
| Large cross-sectional surveys |
|
|
Term
| Incidence and Relative Risk of the obesity epidemic are calculated from _____________________. |
|
Definition
|
|
Term
| Diseases closely related to obesity |
|
Definition
type 2 DM, HT, heart disease, stroke, breast cancer, colon cancer, gallbladder disease, arthritis, physical disability, sleep disturbances, breathing problems
These diseases go in order from most severe/prevalent to least. |
|
|
Term
| Mortality due to obesity is _____________. (Increasing/decreasing) |
|
Definition
|
|
Term
| Morbidity due to obesity is _____________. (Increasing/decreasing) |
|
Definition
|
|
Term
|
Definition
Preventative and diagnostic treatments (doctor visits, etc)
51.6 Billion total:
32.4 billion from Type 2 DM
7.0 billion from CHD
4.3 billion for osteoarthritis
|
|
|
Term
| Indirect costs of obesity |
|
Definition
Costs resulting from the cessation of productivity.
47.6 billion total:
30.7 billion for Type 2 DM
12.9 billion due to osteoarthritis
|
|
|
Term
|
Definition
Spending on Rx for people with a BMI > 30 (obese) is 77% higher than spending for non obese individuals.
The only subset of the population spending more on Rx is the elderly. (This means obesity meds require more spending than cancer, HIV, etc.) |
|
|